Skip to main content
OpenTrials
Completed

NCT Number: NCT04395560

Highlighting the Benefits of a Screening Protocol Delivered by Orthoptists to Identify Visual Impairment in Children Aged 3 to 4

Visual developmental abnormalities affect 10 to 15% of the population under 6 years of age and leads to amblyopia in 30% of cases if left untreated. Untreated amblyopia in adulthood has consequences on the quality of life of individuals but will also represent a cost to society due to the increased risk of visual impairment.

The screening protocol for this study recommends that a screening examination for amblyopia and amblyogenic factors be routinely performed by an orthoptist in children between 3 and 4 year old. This examination should include, as a minimum, a standardised measurement of visual acuity, a cover test and a measurement of refraction by photoscreener. In the event of a positive screening, the child must then be referred to an ophthalmologist so as to complete an ophthalmological examination.

The aim of this protocol is to propose screening tests usually performed with a high specificity, in order to avoid congestion of ophthalmological services (i.e. by avoiding excessive or unnecessary referral of children to the ophthalmologist) without losing sensitivity by combining several tests.

The orthoptists' role in this screening protocol is to facilitate an extensive screening coverage of the population in this age group, as they are more easily accessed by the patients and more equitably spread in the community than ophthalmologists.

Therefore, by initially screening and then referring less children to the ophthalmologist, the aim is to reduce waiting times in the access of ophthalmological services which could be detrimental in terms of treatment success rates for patients acutely needing care.

Based on the referral of children between 3 and 4 years of age by the orthoptist to an ophthalmologist, the analysis of the data from the standard screening protocol used in our centre will enable us to validate it scientifically. The referral thresholds can thus be secondarily adjusted for each test if the initial objectives are not achieved (specificity > 90% and sensitivity > 87%). The aim of this study is also to observe a change in the patient flow by reducing the volume of consultations with the ophthalmologist currently required based on the present referral rate. The efficiency of the screening protocol by calculating the probable economic gain linked to the modification of the screening circuit will be secondarily studying in this protocol

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–4 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ophtalmologie Rive Gauche

Toulouse, Occitanie, 31300, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children from 3 to 4 years old consulting for a screening of visual disorders,
  • Patients registered with French social security scheme,
  • Not participating in any other clinical study,
  • Consent obtained from one of the two parents or the legal representative.

Exclusion criteria

  • Children whose parent or legal representative is vulnerable according to article L1121-6 of the CSP,
  • Children whose parent or legal guardian is under guardianship or trusteeship or under legal protection,
  • Children, whose parent or legal guardian is unable to give consent, or is protected by law.

Treatment and study plan

Primary outcomes

  1. The need to refer the child to an ophthalmologist (YES/NO)

    Time frame: through study completion, an average of 1 year

    the addressing requirements is evaluated by the orthoptist and ophthalmologist based on the patient's chart and clinical examinations

Secondary outcomes

  1. Score of parental satisfaction (algorithmically calculate)

    Time frame: through study completion, an average of 1 year

    Assessed by the Likert scale (satisfaction questionnaire)

  2. The number of ophthalmologic consultations saved

    Time frame: through study completion, an average of 1 year

    Evaluated according to the tariffs of the different nomenclatures of the acts

Sponsors and collaborators

Lead sponsor

Clinique Rive Gauche

Other

Registry information

Acronym: ORTHOPHTALMO

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 20, 2020
Registry last updated
Jul 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.